Review of Chronic Graft-Versus-Host Disease in Children After Allogeneic Stem Cell Transplantation: Nursing Perspective

被引:3
|
作者
Liu, Ying-Mei [1 ]
Hockenberry, Marilyn [1 ]
机构
[1] Chang Gung Univ, Dept Nursing, Chang Gung Inst Technol, Grad Inst Clin Med Sci, Tao Yuan 33302, Taiwan
关键词
allogeneic hematopoietic stem cell transplantation; chronic graft-versus-host disease; children; incidence; risk factors; BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; ACUTE LYMPHOBLASTIC-LEUKEMIA; RISK-FACTORS; T-CELLS; SUPPORTIVE CARE; CLINICAL-TRIALS; DONOR; PROPHYLAXIS;
D O I
10.1177/1043454210377177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review presents a summary of the research literature related to the incidence and risk factors for chronic graft-versus-host disease in children following allogeneic hematopoietic stem cell transplantation. The range of incidence of chronic graft-versus-host disease in children found in this review was large, from 0% to 46%. Incidence of chronic graft-versus-host disease was influenced by sample size, time posttransplantation, and stem cell source. Characteristics of the person (eg, child's age and gender) and disease/treatment (eg, sources of transplant) are associated with chronic graft-versus-host disease in children after stem cell transplantation. Person and disease/treatment characteristics provide a framework for understanding the factors associated with chronic graft-versus-host disease symptom experiences in children after stem cell transplantation. Timely assessment of presenting chronic graft-versus-host disease symptoms is critical for treatment and prognosis. Nursing interventions should focus on educating children and parents about the signs and symptoms of chronic graft-versus-host disease. The summary of supportive nursing care for children with chronic graft-versus-host disease provides important information to tailor effective management strategies for children with chronic graft-versus-host disease.
引用
收藏
页码:6 / 15
页数:10
相关论文
共 50 条
  • [41] Prehematopoietic Stem Cell Transplantation Tear Cytokines as Potential Susceptibility Biomarkers for Ocular Chronic Graft-Versus-Host Disease
    Cocho, Lidia
    Fernandez, Itziar
    Calonge, Margarita
    Sainz de la Maza, Maite
    Rovira, Montserrat
    Stern, Michael E.
    Garcia-Vazquez, Carmen
    Enriquez-de-Salamanca, Amalia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (11) : 4836 - 4846
  • [42] Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    Leithauser, M.
    Kahl, C.
    Aepinus, C.
    Prall, F.
    Maruschke, M.
    Riemer, H.
    Wolff, D.
    Jost, K.
    Hilgendorf, I.
    Freund, M.
    Junghanss, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 251 - 257
  • [43] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [44] Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation
    Gazourian, Lee
    Rogers, Angela J.
    Ibanga, Ruby
    Weinhouse, Gerald L.
    Pinto-Plata, Victor
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Washko, George R.
    Baron, Rebecca M.
    Ho, Vincent T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 404 - 409
  • [45] Novel pre-clinical mouse models for chronic Graft-versus-Host Disease
    Verlaat, Lydia
    Riesner, Katarina
    Kalupa, Martina
    Jung, Beate
    Mertlitz, Sarah
    Schwarz, Constanze
    Mengwasser, Joerg
    Fricke, Claudine
    Penack, Olaf
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [46] Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation
    Cuvelier, Geoff D. E.
    Li, Amanda
    Drissler, Sibyl
    Kariminia, Amina
    Abdossamadi, Sayeh
    Rozmus, Jacob
    Chanoine, Jean-Pierre
    Ng, Bernard
    Mostafavi, Sara
    Brinkman, Ryan R.
    Schultz, Kirk R.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [47] Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients
    Weitz, Marcus
    Strahm, Brigitte
    Meerpohl, Joerg J.
    Bassler, Dirk
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (02):
  • [48] Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience
    Wang, Feiyan
    Cai, Bo
    Wang, Li
    Gu, Zhenyang
    Luo, Lan
    Wei, Huaping
    Zhao, Shasha
    Guan, Lixun
    Wang, Xiaoyu
    Wang, Lili
    Liu, Daihong
    Gao, Chunji
    ANNALS OF TRANSPLANTATION, 2017, 22 : 58 - 65
  • [49] Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
    Mitchell, S. A.
    Leidy, N. Kline
    Mooney, K. H.
    Dudley, W. N.
    Beck, S. L.
    LaStayo, P. C.
    Cowen, E. W.
    Palit, P.
    Comis, L. E.
    Krumlauf, M. C.
    Avila, D. N.
    Atlam, N.
    Fowler, D. H.
    Pavletic, S. Z.
    BONE MARROW TRANSPLANTATION, 2010, 45 (04) : 762 - 769
  • [50] Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS
    Kok, Laurence M. C.
    Bungener, Laura
    De Bock, Geertruida H.
    Biswana, Anouschka
    Van der Wal, Geertiena
    Van Imhoff, Gustaaf W.
    Bellido, Mar
    HUMAN CELL, 2020, 33 (01) : 243 - 251